Hostname: page-component-745bb68f8f-cphqk Total loading time: 0 Render date: 2025-02-10T15:04:44.303Z Has data issue: false hasContentIssue false
  • English
  • Français

Economics and Schizophrenia: The Real Cost

Published online by Cambridge University Press:  06 August 2018

Linda M. Davies  and
Michael F. Drummond
Linda M. Davies*
Affiliation:
Centre for Health Economics, University of York
Michael F. Drummond
Affiliation:
Centre for Health Economics, University of York
*
Linda Davies, Centre for Health Economics, University of York, York YO1 5DD
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The total direct cost of treating schizophrenia in the UK is £397 million, or 1.6% of the total health care budget. Hospital-based and community-based residential care accounts for nearly three-quarters of these costs, while drugs account for only 5%. A conservative estimate of the indirect annual costs of lost production is in the region of £1.7 billion. The heterogeneity of the disease and its outcome means that average treatment costs per person with schizophrenia should be treated with caution; 97% of direct costs are incurred by less than half the patients. Therefore, treatments which reduce the dependence and disability of those most severely affected by schizophrenia are likely to have a large effect on the total cost of the disease to society and may therefore be cost-effective, even though they appear expensive initially.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 165 , Issue S25: New Standards in the Management and Understanding of Schizophrenia , November 1994 , pp. 18 - 21
Copyright
Copyright © 1994 The Royal College of Psychiatrists 

References

Allebeck, P. (1989) Schizophrenia: a life-shortening disease. Schizophrenia Bulletin, 15, 81–89.CrossRefGoogle ScholarPubMed
Anderson, C., Connelly, J., Johnstone, E. C., et al (1991) Disabilities and circumstances of schizophrenic patients: V. Cause of death. British Journal of Psychiatry, 159 (suppl. 13), 30–33.Google Scholar
Andreasen, N. C. (1991) Assessment issues and the cost of schizophrenia. Schizophrenia Bulletin, 17, 475–481.Google Scholar
Central Statistical Office (1992) Social Trends. London: HMSO.Google Scholar
Crow, T. J., MacMillan, J. F., Johnson, A. L., et al (1986) Northwick Park Study of first episodes of schizophrenia II. A randomised controlled trial of prophylactic neuroleptic treatment. British Journal of Psychiatry, 148, 120–127.Google Scholar
Davies, L. M. & Drummond, M. F. (1990) The economic burden of schizophrenia. Psychiatric Bulletin, 14, 522–525.Google Scholar
Davies, L. M. & Drummond, M. F. (1993) Assessment of costs and benefits of drug therapy for treatment-resistant schizophrenia in the United Kingdom. British Journal of Psychiatry, 162, 38–42.Google Scholar
Department of Health (1988) Health and Personal Social Services Statistics for England. London: HMSO.Google Scholar
Department of Health and Social Security (1984) In-patient Statistics from the Mental Health Inquiry for England, 1981. London: HMSO.Google Scholar
Freeman, H. L. & Alpert, M. (1986) Prevalence of schizophrenia in an urban population. British Journal of Psychiatry, 149, 603–611.CrossRefGoogle Scholar
Goldberg, D. (1991) Cost-effectiveness studies in the treatment of schizophrenia: a review. Schizophrenia Bulletin, 17, 453–459.CrossRefGoogle Scholar
Goldberg, D. & Jones, R. J. (1980) The costs and benefits of psychiatric care. In The Social Consequences of Psychiatric Illness (eds Robin, L. N., Clayton, P. J. & Wing, J. K.). New York: Brunner Mazel.Google Scholar
Johnstone, E. C., Crow, T. J., Johnson, A. L., et al (1986) The Northwick Park Study of first episodes of schizophrenia: I. Presentation of the illness and problems relating to admission. British Journal of Psychiatry, 148, 115–120.Google Scholar
Johnstone, E. C., Owens, D. G. C. & Leary, J. (1991) Disabilities and circumstances of schizophrenic patients: VI. Comparison of the 1975–85 cohort with the 1970–75 cohort. British Journal of Psychiatry, 159 (suppl. 13), 34–36.Google Scholar
McCabe, E. (1988) The lost schizophrenics: a retrospective cohort study of discharged patients. Health Bulletin, 46, 26–31.Google Scholar
McGuire, T. G. (1991) Measuring the economic costs of schizophrenia. Schizophrenia Bulletin, 17, 375–388.Google Scholar
Prudo, R. & Blum, H. M. (1987) Five-year outcome and prognosis in schizophrenia. British Journal of Psychiatry, 150, 345–354.Google Scholar
Scottish Home and Health Department (1989) Mental Hospitals in Focus. Edinburgh: HMSO.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.